Apoptosis and Cancer

Last Modified: April 18, 2012

Dates:  June 14-15, 2012 

Location: Cambridge, UK

Web Page URL: http://www.abcam.com/cambridgecancer

Topics Covered: BCL2 Family P53 Family Death Receptors and Inflammation IAP's

Who Should Attend: All researchers/scientists from academia and industry

Agenda: A failure of cells to undergo apoptosis is a common feature of many cancers. During the last 20 years, work in many laboratories has led to the identification and understanding of many of the key players involved in apoptosis. This conference will highlight recent developments in our current understanding of the cellular role of some of these proteins as well as how our knowledge of the basic cellular apoptotic pathways is being used to develop targeted cancer chemotherapeutic agents. Particular attention will be paid to novel agents  that are currently in development or early clinical trials to exploit our understanding of the Bcl-2 family, the p53 family, death receptors and  inhibitor of apoptosis proteins (IAPs).  Discussion sessions will involve members from academia as well as industry.

Registration Information: Early bird discounts and online registration available via the meeting website (www.abcam.com/cambridgecancer)

Continuing Education: No

Audience: HCP